Related Experiment Video

Updated: Oct 9, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

Clinical significance of hepatitis C virus genotypes and quasispecies

P Farci1, R H Purcell

  • 1Department of Medical Sciences, University of Cagliari, Italy. farcip@pacs.unica.it

Seminars in Liver Disease
|July 15, 2000
PubMed

Insights

Hepatitis C virus (HCV) exhibits significant genetic variability, circulating as a quasispecies. This viral diversity impacts persistence, drug resistance, and vaccine development, influencing chronic HCV infection outcomes.

Area of Science:

  • Virology
  • Immunology
  • Genetics

Background:

  • Hepatitis C virus (HCV) infection leads to chronic disease in 85% of cases despite immune responses.
  • HCV possesses high genetic variability due to its error-prone replication, forming quasispecies.
  • This variability is structured hierarchically into genotypes, subgenotypes, isolates, and quasispecies.

Purpose of the Study:

  • To review the current understanding of the biological and clinical implications of Hepatitis C virus genetic variability.
  • To explore the impact of HCV genotypes and quasispecies on disease natural history, transmission, and pathogenesis.
  • To discuss the role of viral genetic diversity in immune escape, antiviral resistance, and vaccine development.

Main Methods:

  • Literature review of studies on Hepatitis C virus genetic variability.
  • Analysis of data concerning the influence of HCV genotypes and quasispecies on clinical outcomes.
  • Synthesis of evidence on the biological mechanisms underlying HCV genetic diversity and its clinical relevance.

Main Results:

  • HCV genotypes may influence antiviral therapy outcomes, but their role in disease natural history and pathogenesis is not fully understood.
  • HCV circulates as a quasispecies, a diverse population of viral genomes.
  • The quasispecies nature of HCV provides a reservoir of variants crucial for viral persistence, immune evasion, and drug resistance.

Conclusions:

  • HCV's genetic variability, particularly its quasispecies nature, has significant clinical implications.
  • Understanding HCV genetic diversity is essential for managing chronic infection, developing effective treatments, and designing vaccines.
  • Further research is needed to fully elucidate the clinical significance of HCV genotypes and quasispecies.

More Related Videos

A Protocol for Analyzing Hepatitis C Virus Replication13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection11:14

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

Related Concept Videos

Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
Human Virome01:26

Human Virome

The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...